Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia

Our results reinforce that genomic surveillance programs are essential for countries to make evidence-driven interventions toward the emergence and circulation of novel SARS-CoV-2 variants.